Telehealth & Digital Health

The virtual ABA therapy leader aims to slash costs and wait times with its AI platform that delivers results in 85% fewer hours than traditional methods.

An innovative absorbable implant shows promise in helping men regain continence faster after prostate cancer surgery, a major quality-of-life concern.

A new AAAHC-accredited surgery center in Tarzana offers advanced spine and joint care, reflecting a national trend toward safer, cost-effective procedures.

A new partnership promises up to 22% savings for employers by integrating deep pharmacy expertise, tackling one of healthcare's most complex challenges.

Machina Medical's novel hydrogel barrier, MFUSE, gains FDA clearance, promising to control severe bleeding in seconds and disrupt the hemostasis market.

For 10 years, McKesson's QCDR has helped oncologists navigate MIPS. Now, new measures aim to elevate patient care and prove the value of treatment.

Midwest retailer Meijer partners with WellSync to offer $29.99 virtual care visits with no insurance, challenging competitors like CVS and Walmart.

The nation's largest occupational health provider acquires four LA-area clinics, signaling a major consolidation push in California's competitive market.

Carrying the Alzheimer's gene, a longevity expert has turned himself into a public experiment, documenting his radical protocol to prevent the disease.

Corvus Pharmaceuticals is set to unveil pivotal early data for its novel eczema drug, soquelitinib, a moment analysts call a critical milestone.

Genmab's antibody drug epcoritamab is the first of its kind to slow cancer progression in a Phase 3 trial for R/R DLBCL, offering a new path for patients.

Crosswalk Therapeutics secures a key grant to develop a therapy targeting the debilitating skeletal disease in Morquio A, a challenge current treatments can't solve.

A new 26-storey tower will add 280 long-term care beds and modern clinics, funded by an innovative philanthropic model that could reshape Canadian healthcare.

As dementia rates soar, one AI firm is using subtle signals from speech and drawing to spot cognitive decline years earlier, moving healthcare toward prevention.

A landmark Nature Medicine publication for OrsoBio's TLC-2716 offers new hope for millions suffering from severe lipid and liver disorders.

The global digital immunoassay market is set to triple, promising to find diseases earlier than ever. But can healthcare systems overcome the high cost?

Jennifer Erickson, a mentee of the retiring CEO, returns to lead Arizona's top lab, signaling a new era of innovation amid industry-wide shifts.

A sudden collapse led to a rare cancer diagnosis for a NJ teen. His story of recovery highlights a therapy that targets tumors while sparing young minds.

Reimbursements are falling and costs are rising, but top allergy practices are boosting revenue by 22%. A new report reveals their data-driven secrets.

A new alliance in healthcare marketing merges pharmaceutical expertise with provider-side insights, leveraging AI and big data to fix a fragmented system.